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BACKGROUND It has been hypothesized that efﬁcacy of DCB can be
improved through treatment of calciﬁed plaque with orbital atherec-
tomy. We evaluated the effects of orbital atherectomy system (OAS)
treatment on paclitaxel distribution in cadaveric samples of human
peripheral arteries with substantial calciﬁed plaque burdens.
METHODS Five fresh human lower limbs were obtained from a
certiﬁed research institution and maintained on ice for further eval-
uation. Computed Tomography (CT) was performed on all limbs to
identify distribution and severity of calciﬁcation in the peripheral
vasculature. Intravascular sheaths were inserted proximally and
distally to simulate the arterial ﬂow. Under ﬂuoroscopic guidance, a
guide catheter was advanced through the sheath into designated pe-
ripheral arteries and angiographic images obtained with contrast
media to identify locations for atherectomy. The superﬁcial femoral,
popliteal and tibial arteries were divided through angiographic mea-
surements into approximately equal segments, and the proximal or
distal segment of each artery treated using the DIAMONDBACK 360
OAS (Cardiovascular Systems, Inc., Saint Paul, MN). Arteries were
explanted and cut in pairs of 3 cm in length along atherectomy-treated
vs. non-treated demarcation lines, lumenally infused with a buffered
solution (PBS/4% BSA) of radiolabeled (14C, 10 mM) or ﬂuorescent
(Oregon Green 488, 10 mM) paclitaxel and incubated in shaking drug-
free buffered solution for 1h at 37⁰C. At the end of 1h, incubated
segments were rinsed and processed for scintillation counting or
ﬂuorescent microscopy.
RESULTS All arteries exhibited high levels of calciﬁcation in CT
angiography. Quantiﬁcation of 14C-labeled paclitaxel revealed a clear
trend of increasing drug deposition in OAS treated tissue segments,
ranging from 20% more in superﬁcial femoral and popliteal arteries to
more than 400% increase in tibial arteries. The average increase of
drug deposit in OAS treated arteries was above 50% (N¼10). Fluores-
cent microscopy revealed distribution patterns that declined with
increasing distance from the lumenal surface and tended to be more
diffuse and extended in OAS treated tissue segments, further sup-
porting the tissue retention trends exhibited by radiolabeled
paclitaxel.
CONCLUSIONS These data illustrate that controlled orbital atherec-
tomy may modify calciﬁed plaque barriers to intravascular drug de-
livery and improve drug distribution throughout the superﬁcial
femoral, popliteal and below the knee artery beds.
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Texas Health Care System, Dallas, TX, Dallas, TXBACKGROUND There is limited data on immediate and longer-term
outcomes of crossing femoropopliteal (FP) chronic total occlusions
(CTO).
METHODS Consecutive patients between January 2006 and March
2015 undergoing endovascular revascularization for symptomatic pe-
ripheral artery disease with FP CTO were analyzed as part of the
Excellence in Peripheral Artery Disease (XLPAD) registry
(NCT01904851). Procedural success was deﬁned as restoration of ﬂow
through the lesion with 30% residual stenosis. Procedural failures
included technical failures (deﬁned as failure to cross the CTO or
failure to renter the true lumen from the subintimal space) and
treatment failures (deﬁned as >30% residual stenosis after successful
crossing). One year outcomes were analyzed.
RESULTS A total of 1100 CTO lesions from 948 patients were included
in the analysis. Procedural success was achieved in 989 (89.9%) CTO,
while procedural failure occurred in 111 (10.1%). Treatment failures
comprised 23 (2.1%) and technical failures 88 (8.0%), with 59 (5.4%)
intraluminal failures to cross and 29 (2.6%) failures to re-enter from
subintimal space (Figure 1). There were signiﬁcantly more surgical
revascularizations following failed procedures compared to
successful (13.5% vs. 3.9%; p<0.0001), although with a lower need
for repeat revascularization procedures (6.3% vs. 20.5%; p¼0.0003).
Need for amputations were similar for patients with failed or
successful procedures (5.4% vs. 3.3%; p¼.26). Univariate analysis
indicated age (p¼.0004), lesion length (p¼.002), heavy calciﬁcation
(p¼.0001), and multilevel FP disease (p¼.001) to be predictors of
procedural failure; lesion calciﬁcation (p¼.03) and multilevel FP
disease (p¼.03) were independent predictors in multivariable
analysis.
CONCLUSIONS Advanced patient age, lesion length, heavy calciﬁca-
tion, and multilevel FP disease are associated with higher procedural
failure rates of crossing FP CTO. Patients experiencing procedural
failures undergo signiﬁcantly higher rates of surgical revasculariza-
tion, albeit with lower need for repeat revascularization.CATEGORIES ENDOVASCULAR: Peripheral Vascular Disease and In-
tervention
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tional approach for recanalization of long below-the-knee (BTK)
chronic total occlusions (CTOs) in patients with critical limb ischemia
(CLI). However, whether primary implantation of self-expanding
nitinol stent in BTK lesions after SIA can improve clinical outcomes is
not known.
METHODS In a multicenter, prospective registry study, we enrolled
90 CLI patients with long BTK lesions (> 5cm), who were treated with
SIA from Oct 2011 to Feb 2015. In all patients, primary stenting with
self-expanding nitinol stent (Maris Deep, Medtronic) was performed
in tibial arteries (anterior tibial artery, n¼65; posterior tibial artery,
n¼25) after SIA. Mean target lesion length and stent length was 20.6 
8.8 cm and 6.1  1.9 cm, respectively. The primary endpoint was
adverse limb events (ALE), a composite of unexpected amputation,
and repeated percutaneous transmembrane angioplasty (PTA) and the
secondary endpoint were limb salvage, all-cause death, major or mi-
nor amputation during the follow up (median 12 months, interquartile
range 6-12 months).
RESULTS Mean age was 70  10 years old and there were 82% men,
76% diabetes mellitus, 13% end stage renal disease patients. Technical
success rate of subintimal angioplasty was 98.9% and procedure-
related complication rate was 2.2%. During the follow up, 15 ALEs
(16.7%, 14 repeated PTA, 1 unexpected minor amputation) occurred.
Limb salvage rate was 100%. In addition, there were 5 planned minor
amputations (6.7%), no major amputation, 2 cardiovascular mortal-
ities (2.2%) and 7 non-cardiovascular mortalities (11.7%). There was no
signiﬁcant difference in age, gender, clinical variables and medica-
tions except for statin (82.7% vs. 53.3% for ALE, p¼0.036) between
ALE and non-ALE group. In a Cox hazard regression analysis, statin
use was associated with decreased ALE after adjusting other risk
factors (hazard ratio 0.315, 95% conﬁdence interval 0.114 – 0.874,
p¼0.026).
CONCLUSIONS Primary stenting with self-expanding nitinol stent
after SIA in BTK CTOs was safe. Limb salvage rate was excellent. The
event rate for repeat interventions appears to be favorable. Statin use
may be beneﬁcial for reducing ALE in CLI patients with long BTK
lesions.
CATEGORIES ENDOVASCULAR: Peripheral Vascular Disease and
Intervention
KEYWORDS Below-the-knee intervention, Critical limb ischemia,
Subintimal stenting
TCT-797
Effect of Hospital Volume on Cost of Hospitalization and Length of Stay of
Percutaneous Peripheral Atherectomy in the United States
Samir Patel,1 Palak Patel,1 Mihir Patel,2 Maheshkumar Desai,3
Apurva Badheka,4 Tejwant Singh1
1Western Reserve Health Education, Youngstown, OH; 2Christus
Highland Hospital, Shreveport, LA; 3Detroit Medical Center, Detroit,
MI; 4Yale School of Medicine, New Haven, CT
BACKGROUND An atherectomy is a minimally invasive catheter-
based procedure to remove plaque from arteries and is particularly
useful in cases where the plaque is very hard due to calciﬁcation.
There is lack of data on the impact of hospital volume on outcomes
following percutaneous peripheral atherectomy of other non-coro-
nary vessels. An aim of study is to see effect of hospital volume on the
length of stay (LOS) and cost of hospitalization of percutaneous pe-
ripheral atherectomy.
METHODS We queried the Healthcare Cost and Utilization Project’s
National Inpatient Sample (NIS) of year of 2012. We identiﬁed pe-
ripheral vascular disease of lower limbs through validated ICD-9 codes
for acute and chronic limb ischemia and atherosclerosis of graft for
age more than 18 years. We sought for only peripheral atherectomy
with using ICD 9 procedural code 17.56. Annual hospital volume was
calculated using unique identiﬁcation numbers and then divided into
tertiles for analysis. Cost to charge ratio ﬁles were merged with NIS to
calculate cost of care. Cost was adjusted for inﬂation in reference to
2012.
RESULTS We identiﬁed a total of 4,203 procedures (weighted n ¼
21,015) with mean age 69.53 years, 56% male and 61% were whites.
Results shown the mean Deyo’s Modiﬁed Charlson score was 2.2,
Hypertension (79%), Diabetes (54%), Congestive heart failure (18%)
and 10% were obese. The average LOS was 6.12  0.11 days and cost of
care was $27,759  339. The highest tertile was showing both shorter
LOS (4.86  0.18 vs 6.79  0.2 days, p<0.0001) and lowerhospitalization cost ($23,062  496 vs $30,794  634, p<0.0001) than
lowest tertile (Figure).
CONCLUSIONS In our study, higher hospital volume was signiﬁcantly
predictive of reduced length of stay by approximately two days and
25% reduction in cost of hospitalization following percutaneous pe-
ripheral atherectomy in the United States.
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BACKGROUND Stent graft placement for femoro-popliteal arterial
obstructive disease is an FDA approved indication for the Gore Via-
bahn (WL Gore, Flagstaff, AZ, USA) stent, for both denovo and instent
restenosis (ISRS) lesions. To date there is little data on Viabahn stent
graft outcomes in patients with De novo and ISRS arterial disease.
METHODS Between 2007 and 2014 we identiﬁed 734 patients under-
went 1573 endovascular interventions in our institution for infra-
inguinal revascularization. Among these, 59 patients had 163 Viabahn
stents placed. Of these, 30 patients had 98 stents placed for ISRS and
29 patients had 65 stents placed for Denovo lesions.
RESULTS The patients in the ISRS group were more likely to have
hypertension, hyperlipidemia, coronary artery disease, history of
prior PCI and chronic kidney disease compared to the patients in the
De novo group. Stents were placed principally for femoro-popliteal
lesions, with mean length of 20 12.5 cm (21.811.5, ISRS Vs 18.213.4,
De novo; p¼0.09). Both groups had low primary patency rates during
one year follow up (51% Vs 49%, OR¼1 (0.5-2.2). Target lesion revas-
cularization(TLR) (58% Vs 25%, p<0.0001, OR¼4.2,CI¼2.1-8.5), cu-
mulative blockage (deﬁned as ISRS and thrombosis) (59% Vs 43%,
p¼0.04, OR¼2,CI¼1-3.6), and surgical revascularization (21% Vs 5%,
OR¼5.6,CI¼1.6 -19) occurred more frequently in the ISRS group than in
the De novo group. Amputation rate (18% Vs 23%, OR 0.7,CI¼0.3-1.8),
Restenosis (47% Vs 35%, OR 1.6,CI¼0.7-3.2) were not statistically
different between the two groups. Mean duration of follow-up was
15.1 13.9 months.
